Studies that compare treatments can lack impact because of obstacles posed by aggressive marketing and financial incentives for certain treatments, because researchers ignore issues important to clinicians and patients, because providers are resistant to change and because the studies' results are ambiguous, according to an analysis in Health Affairs based on interviews with researchers. The analysis recommends matching financial incentives with recommendations for changes in practice and taking doctors' and patients' perspectives into account when designing studies.